Sponsor Pipeline

Can-Fite BioPharma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
2
Phase 3
3
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT04697810
Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)		 overall status: Recruiting → Unknown
Active Trials by Phase
Phase 3
2
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05201404 Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With… Hepatocellular Carcinoma Recruiting
NCT06643260 A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety… Plaque Psoriasis Not Yet Recruiting
Phase 2
NCT06387342 Namodenoson Treatment of Advanced Pancreatic Cancer Pancreatic Adenocarcinoma Recruiting
NCT07410455 An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients… Lowe Syndrome Not Yet Recruiting
Disease Areas
Liver Cancer (1) Pancreatic Cancer (1) Psoriasis (1)
Get alerts when Can-Fite BioPharma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free